Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for Chemotherapy-induced Vomiting in Children
NCT03118986Phase 2Completed
- Sponsor
- SickKids
- Start
- Aug 2017
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in chemotherapy-induced nausea and vomiting (CINV) comparing Olanzapine with Placebo Oral Tablet (2 arms). Primary endpoints: Rate of chemotherapy-induced vomiting (CIV) control up to 8 days and Rate of CIV control during the acute phase up to 8 days. Started Aug 2017; status: completed.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT03118986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03118986.